Transgenic mice expressing human FcγRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cells

Immunology Letters

Volumn 130, Issue 1-2, 2010, Pages 82-88

  Van de Velde, Nicholas C ^a   Mottram, Patricia L ^a   Powell, Maree S ^a   Lim, Bock ^a   Holmdahl, Rikard ^b   Hogarth, P Mark ^a  

^a BURNET INSTITUTE   (Australia)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arthritis; Autoimmune disease; Fc RIIa; Inflammation; Th17

Indexed keywords

COLLAGEN; COLLAGEN ANTIBODY; COLLAGEN II ANTIBODY; FC RECEPTOR IIA; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 17; PRISTANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; C57BL 6 MOUSE; CD4 LYMPHOCYTE COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DISEASE SEVERITY; EFFECTOR CELL; EMBRYO; FEMALE; HISTOPATHOLOGY; LEUKOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TH1 CELL; TH17 CELL; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, TRANSGENIC; RECEPTORS, IGG; T-LYMPHOCYTES; UP-REGULATION;

EID: 77950932487     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.12.005     Document Type: Article

References (47)

1. Ierino F.L., Powell M.S., McKenzie I.F., Hogarth P.M. Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction. J Exp Med 1993, 178:1617-1628.
2. Kleinau S., Martinsson P., Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med 2000, 191:1611-1616.
3. Schiller C., Janssen-Graalfs I., Baumann U., Schwerter-Strumpf K., Izui S., Takai T., et al. Mouse FcγRII is a negative regulator of FcγRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis. Eur J Immunol 2000, 30:481-490.
4. van Lent P.L., Nabbe K., Blom A.B., Holthuysen A.E., Sloetjes A., van de Putte L.B., et al. Role of activatory FcγRI and FcγRIII and inhibitory FcγRII in inflammation and cartilage destruction during experimental antigen-induced arthritis. Am J Pathol 2001, 159:2309-2320.
5. Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002, 2:580-592.
6. Tan Sardjono C., Mottram P.L., Hogarth P.M. The role of FcγRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol 2003, 81:374-381.
7. Bolland S., Ravetch J.V. Spontaneous autoimmune disease in Fc(γ)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000, 13:277-285.
8. Barnes N., Gavin A.L., Tan P.S., Mottram P., Koentgen F., Hogarth P.M. FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 2002, 16:379-389.
9. Hibbs M.L., Classon B.J., Walker I.D., McKenzie I.F., Hogarth P.M. The structure of the murine Fc receptor for IgG. Assignment of intrachain disulfide bonds, identification of N-linked glycosylation sites, and evidence for a fourth form of Fc receptor. J Immunol 1988, 140:544-550.
10. Hibbs M.L., Walker I.D., Kirszbaum L., Pietersz G.A., Deacon N.J., Chambers G.W., et al. The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones. Proc Natl Acad Sci USA 1986, 83:6980-6984.
11. Maxwell K.F., Powell M.S., Hulett M.D., Barton P.A., McKenzie I.F., Garrett T.P., et al. Crystal structure of the human leukocyte Fc receptor, FcγRIIa. Nat Struct Biol 1999, 6:437-442.
12. Powell M.S., Barton P.A., Emmanouilidis D., Wines B.D., Neumann G.M., Pietersz G.A., et al. Biochemical analysis and crystallisation of FcγRIIa, the low affinity receptor for IgG. Immunol Lett 1999, 68:17-23.
13. McKenzie S.E., Taylor S.M., Malladi P., Yuhan H., Cassel D.L., Chien P., et al. The role of the human Fc receptor FcγRIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol 1999, 162:4311-4318.
14. Tan Sardjono C., Mottram P.L., van de Velde N.C., Powell M.S., Power D., Slocombe R.F., et al. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Arthritis Rheum 2005, 52:3220-3229.
15. Kannan K., Ortmann R.A., Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 2005, 12:167-181.
16. Campbell I.K., Hamilton J.A., Wicks I.P. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 2000, 30:1568-1575.
17. Pietersz G.A., Mottram P.L., van de Velde N.C., Sardjono C.T., Esparon S., Ramsland P.A., et al. Inhibition of destructive autoimmune arthritis in FcγRIIa transgenic mice by small chemical entities. Immunol Cell Biol 2009, 87:3-12.
18. Patten C., Bush K., Rioja I., Morgan R., Wooley P., Trill J., et al. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology. Arthritis Rheum 2004, 50:3334-3345.
19. Vigar N.D., Cabrera W.H., Araujo L.M., Ribeiro O.G., Ogata T.R., Siqueira M., et al. Pristane-induced arthritis in mice selected for maximal or minimal acute inflammatory reaction. Eur J Immunol 2000, 30:431-437.
20. Holmdahl R., Rubin K., Klareskog L., Larsson E., Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum 1986, 29:400-410.
21. Nandakumar K.S., Andren M., Martinsson P., Bajtner E., Hellstrom S., Holmdahl R., et al. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcγRIIB. Eur J Immunol 2003, 33:2269-2277.
22. Tate B.J., Witort E., McKenzie I.F., Hogarth P.M. Expression of the high responder/non-responder human FcγRII. Analysis by PCR and transfection into FcR-COS cells. Immunol Cell Biol 1992, 70:79-87.
23. Hogarth P.M., Hulett M.D., Osman N. Fc gamma receptors: gene structure and receptor function. Immunol Res 1992, 11:217-225.
24. Wooley P.H., Seibold J.R., Whalen J.D., Chapdelaine J.M. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989, 32:1022-1030.
25. Nandakumar K., Svenssen L., Holmdahl R. Collagen Type-II specific monoclonal antibody induced arthritis. Description of disease and influence of age, sex and genes. Am J Pathol 2003, 163:1827-1837.
26. Courtenay J.S., Dallman M.J., Dayan A.D., Martin A., Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980, 283:666-668.
27. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
28. Johansson A.C., Sundler M., Kjellen P., Johannesson M., Cook A., Lindqvist A.K., et al. Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcγRIIb and is not associated with loci controlling diabetes. Eur J Immunol 2001, 31:1847-1856.
29. Salmon J.E., Edberg J.C., Brogle N.L., Kimberly R.P. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992, 89:1274-1281.
30. Wooley P.H. Collagen-induced arthritis in the mouse. Methods Enzymol 1988, 162:361-373.
31. Holmdahl R., Andersson M., Goldschmidt T.J., Gustafsson K., Jansson L., Mo J.A. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990, 118:193-232.
32. Holmberg J., Tuncel J., Yamada H., Lu S., Olofsson P., Holmdahl R. Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol 2006, 176:1172-1179.
33. Burkhardt H., Koller T., Engstrom A., Nandakumar K.S., Turnay J., Kraetsch H.G., et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum 2002, 46:2339-2348.
34. Gray R.E., Seng N., Mackay I.R., Rowley M.J. Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro. J Immunol Methods 2004, 285:55-61.
35. Nandakumar K.S., Collin M., Olsen A., Nimmerjahn F., Blom A.M., Ravetch J.V., et al. Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis. Eur J Immunol 2007, 37:2973-2982.
36. Hietala M.A., Nandakumar K.S., Persson L., Fahlen S., Holmdahl R., Pekna M. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol 2004, 34:1208-1216.
37. Bartholomew J.S., Evanson J.M., Woolley D.E. Serum IgE anti-cartilage collagen antibodies in rheumatoid patients. Rheumatol Int 1991, 11:37-40.
38. Cook A.D., Rowley M.J., Mackay I.R., Gough A., Emery P. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum 1996, 39:1720-1727.
39. Brunsberg U., Gustafsson K., Jansson L., Michaelsson E., Ahrlund-Richter L., Pettersson S., et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 1994, 24:1698-1702.
40. Nandakumar K.S., Backlund J., Vestberg M., Holmdahl R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res Ther 2004, 6:R544-550.
41. Ohmura K., Johnsen A., Ortiz-Lopez A., Desany P., Roy M., Besse W., et al. Variation in IL-1beta gene expression is a major determinant of genetic differences in arthritis aggressivity in mice. Proc Natl Acad Sci USA 2005, 102:12489-12494.
42. Ohmura K., Nguyen L.T., Locksley R.M., Mathis D., Benoist C. Interleukin-4 can be a key positive regulator of inflammatory arthritis. Arthritis Rheum 2005, 52:1866-1875.
43. Alleva D.G., Johnson E.B., Wilson J., Beller D.I., Conlon P.J. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity. J Leukoc Biol 2001, 69:440-448.
44. Szekanecz Z., Koch A.E. Mechanisms of disease: angiogenesis in inflammatory diseases. Nat Clin Pract 2007, 3:635-643.
45. + T-cell dependent. Immunology 1997, 90:81-86.
46. O'Connor R.A., Prendergast C.T., Sabatos C.A., Lau C.W., Leech M.D., Wraith D.C., et al. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 2008, 181:3750-3754.
47. Sverdrup B., Kallberg H., Bengtsson C., Lundberg I., Padyukov L., Alfredsson L., et al. Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arthritis Res Ther 2005, 7:R1296-R1303.